^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
lifastuzumab vedotin (DNIB0600A)
i
Other names: DNIB0600A, RG7599, DNIB-0600A, RG-7599, anti-NaPi2b ADC
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Roche
Drug class:
Microtubule inhibitor, NaPi2b-targeted antibody-drug conjugate
Related drugs:
